The Role Of Omega 3 Supplementation In Repeated Transient Ischemic Attack : A Case Report
Keywords:
Omega-3, PUFA, stroke, transient ischemic attack, nutritionAbstract
Introduction: According to a 2021 worldwide analysis, 1 in 4 adults will suffer a stroke in their lifetime. Risk factors include hypertension, diabetes mellitus, dyslipidemia, and atrial fibrillation. Lifestyle is a critical factor in stroke prevention. More importantly, dietary habits were shown to be the most relevant. To reduce the risk of ischemic stroke, nutritional approaches have historically focused on high-fiber diets with low in sodium, saturated fat, and cholesterol. It is well known that n-3 PUFAs reduce the risk of cardiovascular diseases. Case Report: A 65-years old woman present with headache and myalgia. She was grade I obese with a body weight of 69 kg. The patient has history of transient ischemic attack (TIA) twice within a year. There is a history of type 1 diabetes mellitus thus taking insulin for a year and hypertension for 2 years. On examination, the blood pressure was 170/90 mmHg. Both of her foot were swollen. Laboratory test results were normal. History of medication includes Amlodipine, Candesartan, Furosemide, dan Glargine. Omega 3 supplementation was planned to reduce inflammation and risk of future episodes of stroke. Conclusion: Omega-3 PUFA have various pharmacological activities, such as anti-inflammatory, anti-thrombosis, anti-atherosclerosis, reduce blood lipid levels and significantly improve endothelial dysfunction. Omega-3 is also beneficial in obesity and diabetics, which are risk factors of stroke or TIA.
References
Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018 Apr;38(2):208–11.
Niewada M, Michel P. Lifestyle modification for stroke prevention: facts and fiction. Curr Opin Neurol. 2016 Feb;29(1):9–13.
Ueno Y, Miyamoto N, Yamashiro K, Tanaka R, Hattori N. Omega-3 Polyunsaturated Fatty Acids and Stroke Burden. Int J Mol Sci. 2019 Nov 7;20(22):5549.
Amin HP, Madsen TE, Bravata DM, Wira CR, Johnston SC, Ashcraft S, et al. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association. Stroke. 2023 Mar;54(3):e109–21.
Garg A, Maran I, Amin H, Vlieks K, Neuschatz K, Coppola A, et al. Expedited and Comprehensive Management of Low-Risk TIA Patients in the Emergency Department is Safe and Less Costly. Journal of Stroke and Cerebrovascular Diseases [Internet]. 2021 Oct 1 [cited 2024 Sep 13];30(10). Available from: https://www.strokejournal.org/article/S1052-3057(21)00421-3/abstract
Wintermark M, Sanelli PC, Albers GW, Bello JA, Derdeyn CP, Hetts SW, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol. 2013 Nov;10(11):828–32.
Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015 Apr;14(4):377–87.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364–467.
Panuganti KK, Tadi P, Lui F. Transient Ischemic Attack. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK459143/
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215–25.
Perry JJ, Yadav K, Syed S, Shamy M. Transient ischemic attack and minor stroke: diagnosis, risk stratification and management. CMAJ. 2022 Oct 11;194(39):E1344–9.
Gladstone DJ, Lindsay MP, Douketis J, Smith EE, Dowlatshahi D, Wein T, et al. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020. Canadian Journal of Neurological Sciences. 2022 May;49(3):315–37.
Bloomgarden Z, Handelsman Y. Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC. American Journal of Preventive Cardiology. 2020 Mar 1;1:100007.
Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelić D, Kahleová H, et al. DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Nutrients. 2019 Feb 5;11(2):338.
Parikh NS, Omran SS, Kamel H, Elkind MSV, Willey JZ. Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review. Journal of Clinical Neuroscience. 2020 Aug 1;78:236–41.
Fadhilah D, Wulandari Y. Pengaruh Suplementasi Omega-3 Terhadap Luaran Klinis Pasien Stroke Iskemik: Tinjauan Literatur. Jurnal Sehat Indonesia (JUSINDO). 2024 Feb 21;6(02):422–30.
Albracht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, et al. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. The Journal of Nutritional Biochemistry. 2018 Aug;58:1–16.
Xu Q, Du L, Gu H, Ji M, Zhan L. The effect of omega-3 polyunsaturated fatty acids on stroke treatment and prevention: a systematic review and meta-analysis. Nutr Hosp [Internet]. 2022 [cited 2024 Sep 14]; Available from: https://www.nutricionhospitalaria.org/articles/04148/show
DiNicolantonio JJ, OKeefe J. Importance of maintaining a low omega-6/omega-3 ratio for reducing platelet aggregation, coagulation and thrombosis. Open Heart. 2019 May 1;6(1):e001011.
O’Keefe JH, Tintle NL, Harris WS, O’Keefe EL, Sala-Vila A, Attia J, et al. Omega-3 Blood Levels and Stroke Risk: A Pooled and Harmonized Analysis of 183 291 Participants From 29 Prospective Studies. Stroke. 2024 Jan;55(1):50–8.
Walker RE, Jackson KH, Tintle NL, Shearer GC, Bernasconi A, Masson S, et al. Predicting the effects of supplemental EPA and DHA on the omega-3 index. The American Journal of Clinical Nutrition. 2019 Oct 1;110(4):1034–40.
Bonetti NR, Liberale L, Akhmedov A, Pasterk L, Gobbato S, Puspitasari YM, et al. Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke. Atherosclerosis. 2021 May 1;325:89–98.
Gray B, Steyn F, Davies PSW, Vitetta L. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr. 2013 Dec;67(12):1234–42.
Parmar RM, Can AS. Dietary Approaches to Obesity Treatment. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK574576/
Hwalla N, Jaafar Z. Dietary Management of Obesity: A Review of the Evidence. Diagnostics (Basel). 2020 Dec 25;11(1):24.
Jiao J. The Role of Nutrition in Obesity. Nutrients. 2023 May 30;15(11):2556.
Lee V. Introduction to the dietary management of obesity in adults. Clinical Medicine. 2023 Jul 1;23(4):304–10.
Delpino FM, Figueiredo LM, da Silva BGC. Effects of omega-3 supplementation on body weight and body fat mass: A systematic review. Clinical Nutrition ESPEN. 2021 Aug 1;44:122–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pretty Grace Zalukhu, Corry Ida Hinaya Zalukhu (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
